From “Trump” to “Russian” to “dentist,” the only way to gaze into the Epstein-files abyss is through a keyword-size hole.
An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.
Pam Bondi wrote in a Saturday letter the DOJ has released "all" Epstein-related files and listed a number of "politically ...
This list will be updated and includes people who have faced concrete consequences, such as the loss of their position, as a ...
Patrick Healy, an assistant managing editor who oversees The Times’s journalistic standards, talked with four of the journalists who are working on the Epstein files to kick around those questions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results